Fexofenadine hydrochloride vs Mepolizumab
National NHS prescribing compared (Prescription Cost Analysis)
Fexofenadine hydrochloride was dispensed 672,638.0× as often as Mepolizumab in May 2026 — 672,638 items versus 1 in England.
672,638items
Fexofenadine hydrochloride · May 2026
NHSBSA Prescription Cost Analysis
1items
Mepolizumab · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Fexofenadine hydrochloride versus Mepolizumab: national items dispensed by month
▬ Fexofenadine hydrochloride · ╌ Mepolizumab
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Fexofenadine hydrochloride | Mepolizumab |
|---|---|---|
| Items, May 2026 | 672,638 | 1 |
| Items, last 12 months | 7,108,597 | 2 |
| Net ingredient cost, May 2026 | £2,537,332 | £3,360 |
See the full profile for Fexofenadine hydrochloride or Mepolizumab.